Pharmcoepidemiologist
Division of Epidemiology, Office of Surveillance and epidemiology,Center for Drug Evaluation and Research, US Food and Drug Administration, Maryland, United States
US FDA (Employment, This abstract reflects the views of the author and should not be construed to represent FDA’s views or policies.)
OP-27E - Categorization of COVID-19 Severity to Determine Mortality Risk
Tuesday, August 24, 2021
1:45 PM – 3:30 PM US Eastern Time
Tuesday, August 24, 2021
6:45 PM – 7:45 PM US Eastern Time